The U.K. Parliament recently opened a debate about psychedelics reform. Labor MP Charlotte Nichols opened the discussion around the need for medical access to psilocybin-assisted therapy.

In a call supported by politician, the Royal College of Psychiatrists, the Campaign Against Living Miserably (CALM,) the Conservative Drug Reform Group and several other organizations, Nichols stated that there is “an urgent and medically-justified need” to reschedule psilocybin under the 2001 regulations.

After a brief review of psychedelics use and history starting with its origins from 7000-9000 BC to its setbacks and criminalization following 1970’s counterculture despite their proven health benefits, Nichols said it’s been over 50 years since the world –and the U.K.– is “in a stasis” on the topic.

“There are serious and considerable barriers to legitimate research, associated with Schedule I regulations,” she said. “While current legislation does not preclude scientific research with these drugs, it does make them significantly more difficult, time-consuming and costly to study.”

She provided an example of a researcher that found he had to invest £20,000 …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.